Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Allarity Therapeutics, Inc. (ALLR)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 22, 2026 | CORRESP | Neutral/Informational | Moderate | Allarity Therapeutics, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it become effective on April 24, 2… | Read Filing EDGAR |
| Feb. 19, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has informed Allarity Therapeutics, Inc. that they will not review the company's registration statement filed on February 12, 2026. This decision emphasizes the company's … | Read Filing EDGAR |
| Dec. 4, 2025 | CORRESP | Neutral/Informational | Moderate | Allarity Therapeutics, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it become effective on December 5,… | Read Filing EDGAR |
| Sep. 30, 2025 | CORRESP | Neutral/Informational | Moderate | Allarity Therapeutics, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it become effective on September 3… | Read Filing EDGAR |
| Sep. 29, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Allarity Therapeutics, Inc. that it will not review their registration statement filed on September 25, 2025. The letter emphasizes that the responsibi… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.